Dr. Mogul is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 North Wolfe Street
Baltimore, MD 21287Phone+1 443-997-5437Fax+1 410-367-2762
Education & Training
- Johns Hopkins UniversityFellowship, Pediatric Gastroenterology, 2009 - 2012
- Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 2006 - 2009
- Albert Einstein College of MedicineClass of 2006
Certifications & Licensure
- CA State Medical License 2007 - Present
- MD State Medical License 2012 - 2025
- NC State Medical License 2020 - 2022
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- A Study of mDOT for Immunosuppressant Adherence in Solid Organ Transplant Recipients Start of enrollment: 2020 Nov 20
Publications & Presentations
PubMed
- Maralixibat Reduces Serum Bile Acids and Improves Cholestatic Pruritus in Adolescents With Alagille Syndrome.Gideon Hirschfield, Shannon M Vandriel, Douglas B Mogul, Marshall Baek, Pamela Vig
Liver International. 2025-02-01 - 2 citationsMaralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.Alexander G Miethke, Adib Moukarzel, Gilda Porta, Joshue Covarrubias Esquer, Piotr Czubkowski
The Lancet. Gastroenterology & Hepatology. 2024-07-01 - 5 citationsEvent-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA.Bettina E Hansen, Shannon M Vandriel, Pamela Vig, Will Garner, Douglas B Mogul
Hepatology. 2024-06-01
Press Mentions
- Mirum Pharmaceuticals to Showcase LIVMARLI® (Maralixibat) Data at EASL and ESPGHAN Annual CongressesJune 13th, 2022
- Young Transplant Recipients Have Better Covid-19 Vaccine Response Than Adult CounterpartsSeptember 30th, 2021
- Natural Language Processing Helps Evaluate Electronic Messages from ESLD PatientsNovember 7th, 2019
- Join now to see all
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/douglas-mogul
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: